Pfizer Inc (PFE)

$25.08 -0.13 (-0.52%)
Market Cap 143.68B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 8.47
Forward PE 8.44
Profit Margin 12.42%
Debt to Equity Ratio 0.71
Volume 40,675,719
Avg Vol 36,494,223
Day's Range N/A - N/A
Shares Out 5.70B
Stochastic %K 17%
Beta 0.34
Analysts Sell
Price Target $29.28

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
CosmicMiner
CosmicMiner Jun. 22 at 10:15 PM
$PFE Pfizer announced that sigvotatug vedotin, the ADC acquired through its $43B Seagen deal, failed to significantly improve overall survival vs. docetaxel in a Phase 3 advanced non-small cell lung cancer trial. The company will continue its development, including an ongoing Phase 3 study in combination with Merck’s Keytruda for 1L lung cancer.
0 · Reply
Micheal_Pothead
Micheal_Pothead Jun. 22 at 9:53 PM
$PFE @Willieberich dont you have some simping to be doing?
1 · Reply
breakawayrider
breakawayrider Jun. 22 at 9:46 PM
$PFE that shareholder value bourla speaks of?
0 · Reply
tmgolf123
tmgolf123 Jun. 22 at 9:44 PM
$PFE this stock sucks
0 · Reply
MarketArchitectt
MarketArchitectt Jun. 22 at 9:37 PM
Watching $FCX $PFE $PSKY closely. Current behavior suggests semiconductor cycle view, but I am not overcommitting yet.
0 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Jun. 22 at 9:36 PM
$PFE - Our pfounder is pfurious!
0 · Reply
Micheal_Pothead
Micheal_Pothead Jun. 22 at 9:30 PM
$PFE like 1/150th average daily volume in AH btw
1 · Reply
flychicken1991
flychicken1991 Jun. 22 at 9:27 PM
$PFE Negative: Price could move higher only if adoption, economics, or regulatory odds are specific enough to change valuation. Key news: Pfizer's Phase 3 Study of Sigvotatug Vedotin Misses Overall Survival Endpoint. Full catalyst map + source details on NewsImpact: https://clawpool.hihired.org/newsimpact/ticker/PFE?utm_source=stocktwits&utm_medium=parent_url Not financial advice.
0 · Reply
Micheal_Pothead
Micheal_Pothead Jun. 22 at 9:26 PM
$PFE
1 · Reply
flychicken1991
flychicken1991 Jun. 22 at 9:22 PM
$PFE Negative: Price could move higher only if adoption, economics, or regulatory odds are specific enough to change valuation. Key news: Pfizer's Phase 3 Study of Sigvotatug Vedotin Misses Overall Survival Endpoint. Full catalyst map + source details on NewsImpact: https://clawpool.hihired.org/newsimpact/ticker/PFE?utm_source=stocktwits&utm_medium=parent_url Not financial advice.
0 · Reply
Latest News on PFE
Wall Street loves growth stocks — but these 10 ‘losers' are primed to win

Jun 22, 2026, 2:32 PM EDT - 3 hours ago

Wall Street loves growth stocks — but these 10 ‘losers' are primed to win

ACHR AGCO COF DHI DVN EOG TSN

Pfizer (PFE) Shares Sink After Surprise CFO Exit

2026-06-18T18:35:11.000Z - 4 days ago

Pfizer (PFE) Shares Sink After Surprise CFO Exit

Pfizer reaffirms all components of FY26 guidance

2026-06-18T17:30:31.000Z - 4 days ago

Pfizer reaffirms all components of FY26 guidance

Pfizer CFO Dave Denton to step down, Cecile Guegan named interim CFO

2026-06-18T10:52:33.000Z - 4 days ago

Pfizer CFO Dave Denton to step down, Cecile Guegan named interim CFO

Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:52 AM EDT - 4 days ago

Pfizer CFO Dave Denton to step down, leave company in August

Pfizer Announces Chief Financial Officer Transition

Jun 18, 2026, 6:45 AM EDT - 4 days ago

Pfizer Announces Chief Financial Officer Transition

Pfizer CEO warns German investment at risk over drug pricing policies

Jun 10, 2026, 7:56 AM EDT - 12 days ago

Pfizer CEO warns German investment at risk over drug pricing policies

Pfizer upgraded to Sector Perform from Underperform at RBC Capital

2026-06-09T21:05:52.000Z - 13 days ago

Pfizer upgraded to Sector Perform from Underperform at RBC Capital

Pfizer upgraded to Sector Perform at RBC Capital amid more balanced risk-reward

2026-06-09T21:05:12.000Z - 13 days ago

Pfizer upgraded to Sector Perform at RBC Capital amid more balanced risk-reward

Want to Avoid the Whipsawing Tech Stocks? Dollar General and 7 Others to Buy.

Jun 9, 2026, 2:07 PM EDT - 13 days ago

Want to Avoid the Whipsawing Tech Stocks? Dollar General and 7 Others to Buy.

DG ALGN BBY BIIB CVS VZ

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

Jun 9, 2026, 9:20 AM EDT - 13 days ago

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

AMGN JNJ LLY MRK NVO

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

Jun 9, 2026, 3:20 AM EDT - 13 days ago

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

BMY LLY MRK RDW UTHR XBI

Pfizer Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 8, 2026, 8:00 AM EDT - 14 days ago

Pfizer Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Pfizer says FDA approves expanded indication for Hympavzi

2026-06-08T10:51:57.000Z - 14 days ago

Pfizer says FDA approves expanded indication for Hympavzi

US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:49 AM EDT - 14 days ago

US FDA approves Pfizer's bleeding disorder drug for children

U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

Jun 8, 2026, 6:45 AM EDT - 14 days ago

U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

Pfizer presents results from Phase 2b studies of berobenatide

2026-06-07T22:00:49.000Z - 15 days ago

Pfizer presents results from Phase 2b studies of berobenatide

Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 16 days ago

Pfizer Transcript: Study update

Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 16 days ago

Pfizer Slides: Study update

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Jun 6, 2026, 9:06 AM EDT - 16 days ago

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide

Jun 6, 2026, 9:00 AM EDT - 16 days ago

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide

Chai Discovery Announces License Agreement with Pfizer to Accelerate Drug Discovery with AI

Jun 4, 2026, 10:00 AM EDT - 18 days ago

Chai Discovery Announces License Agreement with Pfizer to Accelerate Drug Discovery with AI

Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup

Jun 4, 2026, 6:40 AM EDT - 18 days ago

Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup

LLY

Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 2:00 PM EDT - 19 days ago

Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Jun 1, 2026, 10:00 AM EDT - 21 days ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Pfizer announces results from Cohort 3 on Bratovi with cetuximab, Folfiri

2026-05-31T13:45:07.000Z - 22 days ago

Pfizer announces results from Cohort 3 on Bratovi with cetuximab, Folfiri

Pfizer announces results from Phase 3 Talapro-3 study of Talzenna, Xtandi

2026-05-31T13:25:52.000Z - 22 days ago

Pfizer announces results from Phase 3 Talapro-3 study of Talzenna, Xtandi

Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

May 31, 2026, 8:00 AM EDT - 22 days ago

Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

Mailbag: A Follow-Up on Pfizer & Other Questions

May 30, 2026, 9:22 AM EDT - 23 days ago

Mailbag: A Follow-Up on Pfizer & Other Questions

AGNC LAND NLY PFFA

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

May 30, 2026, 8:00 AM EDT - 23 days ago

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

Seven-Year Analysis from Pfizer's LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer

May 29, 2026, 8:00 AM EDT - 24 days ago

Seven-Year Analysis from Pfizer's LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer

Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion

May 28, 2026, 11:10 PM EDT - 24 days ago

Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion

China's Innovent Biologics, Pfizer strike up to $10.5 billion cancer drug deal

May 28, 2026, 7:19 PM EDT - 24 days ago

China's Innovent Biologics, Pfizer strike up to $10.5 billion cancer drug deal

Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 28, 2026, 7:00 PM EDT - 24 days ago

Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 28, 2026, 7:00 PM EDT - 24 days ago

Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

May 27, 2026, 10:00 AM EDT - 26 days ago

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

Sarah Cannon Research Institute Announces Strategic Oncology Research Collaboration with Pfizer

May 20, 2026, 9:00 AM EDT - 4 weeks ago

Sarah Cannon Research Institute Announces Strategic Oncology Research Collaboration with Pfizer

Pfizer's pneumococcal shot shows stronger immune response in mid-stage trial

May 20, 2026, 5:08 AM EDT - 4 weeks ago

Pfizer's pneumococcal shot shows stronger immune response in mid-stage trial

Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results

May 20, 2026, 5:05 AM EDT - 4 weeks ago

Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results

Astellas to Present Data on Long-Term Outcomes and Clinical Use of Its Portfolio Across Disease Stages at ASCO 2026

May 18, 2026, 8:00 AM EDT - 5 weeks ago

Astellas to Present Data on Long-Term Outcomes and Clinical Use of Its Portfolio Across Disease Stages at ASCO 2026

Quest Diagnostics, Altria, and 12 More Stocks That Are Coming Back to Life After a Rough Patch

May 14, 2026, 2:22 PM EDT - 5 weeks ago

Quest Diagnostics, Altria, and 12 More Stocks That Are Coming Back to Life After a Rough Patch

DGX MO CL

European Commission Approves Pfizer's HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors

May 13, 2026, 6:45 AM EDT - 5 weeks ago

European Commission Approves Pfizer's HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors

Rigel strikes licensing deal for Pfizer and Arvinas' breast cancer drug

May 12, 2026, 8:00 AM EDT - 5 weeks ago

Rigel strikes licensing deal for Pfizer and Arvinas' breast cancer drug

ARVN RIGL

Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)

May 12, 2026, 7:00 AM EDT - 5 weeks ago

Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)

ARVN

Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC

May 5, 2026, 4:09 PM EDT - 6 weeks ago

Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC

Pfizer CEO on AI-designed molecule, and race to use new tech

May 5, 2026, 4:02 PM EDT - 6 weeks ago

Pfizer CEO on AI-designed molecule, and race to use new tech

3 Dividend Stocks for May 2026

May 5, 2026, 11:30 AM EDT - 6 weeks ago

3 Dividend Stocks for May 2026

SYY WSO

Pfizer Earnings Call Transcript: Q1 2026

May 5, 2026, 10:00 AM EDT - 6 weeks ago

Pfizer Earnings Call Transcript: Q1 2026

Pfizer Earnings release: Q1 2026

May 5, 2026, 10:00 AM EDT - 6 weeks ago

Pfizer Earnings release: Q1 2026

Pfizer Quarterly report: Q1 2026

May 5, 2026, 10:00 AM EDT - 6 weeks ago

Pfizer Quarterly report: Q1 2026

Pfizer Slides: Q1 2026

May 5, 2026, 10:00 AM EDT - 6 weeks ago

Pfizer Slides: Q1 2026

Pfizer Posts Better-Than-Expected Revenue, Profit

May 5, 2026, 8:35 AM EDT - 6 weeks ago

Pfizer Posts Better-Than-Expected Revenue, Profit

Pfizer Revenue Rises But Profit Falls Amid Boosted R&D Spending

May 5, 2026, 7:23 AM EDT - 6 weeks ago

Pfizer Revenue Rises But Profit Falls Amid Boosted R&D Spending

Pfizer Stock Edges Higher as Earnings and Revenue Beat Estimates

May 5, 2026, 7:06 AM EDT - 6 weeks ago

Pfizer Stock Edges Higher as Earnings and Revenue Beat Estimates

Why selling these 3 dividend stocks could be a mistake

May 5, 2026, 7:05 AM EDT - 6 weeks ago

Why selling these 3 dividend stocks could be a mistake

EPD UPS

Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth

May 5, 2026, 6:55 AM EDT - 6 weeks ago

Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth

Pfizer beats first-quarter profit estimates on strong demand for blood thinner Eliquis

May 5, 2026, 6:51 AM EDT - 6 weeks ago

Pfizer beats first-quarter profit estimates on strong demand for blood thinner Eliquis

Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance

May 5, 2026, 6:45 AM EDT - 6 weeks ago

Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance

US FDA approves Pfizer, Arvinas' breast cancer drug

May 1, 2026, 12:37 PM EDT - 7 weeks ago

US FDA approves Pfizer, Arvinas' breast cancer drug

ARVN

Pfizer's blood cancer drug meets main goal in late-stage trial

Apr 29, 2026, 7:42 AM EDT - 7 weeks ago

Pfizer's blood cancer drug meets main goal in late-stage trial

Pfizer's ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma

Apr 29, 2026, 6:45 AM EDT - 7 weeks ago

Pfizer's ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma

Pfizer secures deals to keep heart drug free of generic rivals until 2031

Apr 28, 2026, 10:41 AM EDT - 7 weeks ago

Pfizer secures deals to keep heart drug free of generic rivals until 2031

Pfizer Reaches Three Settlement Agreements for VYNDAMAX

Apr 28, 2026, 10:17 AM EDT - 7 weeks ago

Pfizer Reaches Three Settlement Agreements for VYNDAMAX

Bristol Myers, Pfizer to offer blockbuster blood thinner through Mark Cuban's online pharmacy

Apr 24, 2026, 8:36 AM EDT - 2 months ago

Bristol Myers, Pfizer to offer blockbuster blood thinner through Mark Cuban's online pharmacy

BMY

Pfizer Transcript: AGM 2026

Apr 23, 2026, 9:00 AM EDT - 2 months ago

Pfizer Transcript: AGM 2026

Pfizer Declares Second-Quarter 2026 Dividend

Apr 22, 2026, 4:45 PM EDT - 2 months ago

Pfizer Declares Second-Quarter 2026 Dividend

Pfizer GLP-1 weight loss drug available for pre-order in China

Apr 22, 2026, 5:18 AM EDT - 2 months ago

Pfizer GLP-1 weight loss drug available for pre-order in China

Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026

Apr 21, 2026, 11:51 AM EDT - 2 months ago

Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026

CosmicMiner
CosmicMiner Jun. 22 at 10:15 PM
$PFE Pfizer announced that sigvotatug vedotin, the ADC acquired through its $43B Seagen deal, failed to significantly improve overall survival vs. docetaxel in a Phase 3 advanced non-small cell lung cancer trial. The company will continue its development, including an ongoing Phase 3 study in combination with Merck’s Keytruda for 1L lung cancer.
0 · Reply
Micheal_Pothead
Micheal_Pothead Jun. 22 at 9:53 PM
$PFE @Willieberich dont you have some simping to be doing?
1 · Reply
breakawayrider
breakawayrider Jun. 22 at 9:46 PM
$PFE that shareholder value bourla speaks of?
0 · Reply
tmgolf123
tmgolf123 Jun. 22 at 9:44 PM
$PFE this stock sucks
0 · Reply
MarketArchitectt
MarketArchitectt Jun. 22 at 9:37 PM
Watching $FCX $PFE $PSKY closely. Current behavior suggests semiconductor cycle view, but I am not overcommitting yet.
0 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Jun. 22 at 9:36 PM
$PFE - Our pfounder is pfurious!
0 · Reply
Micheal_Pothead
Micheal_Pothead Jun. 22 at 9:30 PM
$PFE like 1/150th average daily volume in AH btw
1 · Reply
flychicken1991
flychicken1991 Jun. 22 at 9:27 PM
$PFE Negative: Price could move higher only if adoption, economics, or regulatory odds are specific enough to change valuation. Key news: Pfizer's Phase 3 Study of Sigvotatug Vedotin Misses Overall Survival Endpoint. Full catalyst map + source details on NewsImpact: https://clawpool.hihired.org/newsimpact/ticker/PFE?utm_source=stocktwits&utm_medium=parent_url Not financial advice.
0 · Reply
Micheal_Pothead
Micheal_Pothead Jun. 22 at 9:26 PM
$PFE
1 · Reply
flychicken1991
flychicken1991 Jun. 22 at 9:22 PM
$PFE Negative: Price could move higher only if adoption, economics, or regulatory odds are specific enough to change valuation. Key news: Pfizer's Phase 3 Study of Sigvotatug Vedotin Misses Overall Survival Endpoint. Full catalyst map + source details on NewsImpact: https://clawpool.hihired.org/newsimpact/ticker/PFE?utm_source=stocktwits&utm_medium=parent_url Not financial advice.
0 · Reply
MrPeanutEsquire
MrPeanutEsquire Jun. 22 at 9:19 PM
$PFE Ok, so it doesn't work on cancer. Have we tried all the other application possibilities though? Can it be used as a toilet cleaner? How are its lubrication properties? We could be sitting on the next WD-40 and not even know it. Just saying, might want to think about that before you sell the stock.
1 · Reply
focafoca99
focafoca99 Jun. 22 at 9:19 PM
$PFE commented that its Phase 3 SigVie-002 trial missed the primary overall survival endpoint, though a trend favored the drug in https://www.rapidticker.com/news/pfe-pfizer-announces-topline-phase-3-8b4bd5
0 · Reply
YuhhhhhU
YuhhhhhU Jun. 22 at 9:18 PM
$PFE buy zone
0 · Reply
jdlman
jdlman Jun. 22 at 9:18 PM
$PFE oh my
0 · Reply
Micheal_Pothead
Micheal_Pothead Jun. 22 at 9:17 PM
$PFE I’m genuinely sick to my stomach
1 · Reply
Micheal_Pothead
Micheal_Pothead Jun. 22 at 9:15 PM
$PFE never goes up on good trail news though
0 · Reply
pasuny
pasuny Jun. 22 at 9:14 PM
$PFE miserable worthless pathetic disgusting filthy piece of sxxt
0 · Reply
Micheal_Pothead
Micheal_Pothead Jun. 22 at 9:12 PM
$PFE officially red YTD
0 · Reply
Micheal_Pothead
Micheal_Pothead Jun. 22 at 9:08 PM
$PFE oh my god..
1 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Jun. 22 at 9:07 PM
$PFE - That article is terrible!!! Ghastly, unrealistic journalists! (We aren't a pharmaceutical giant, not anymore!)
0 · Reply
Typecheck
Typecheck Jun. 22 at 9:01 PM
$PFE what is going on with the after market
1 · Reply
Wallst45
Wallst45 Jun. 22 at 8:59 PM
$PFE -Pfizer’s Lung Cancer drug trial fails primary endpoint https://ca.investing.com/news/stock-market-news/pfizer-lung-cancer-drug-trial-fails-primary-endpoint-93CH-4701833
1 · Reply